Answer
Most is eliminated unchanged through healthy kidneys, but low-level gadolinium retention can occur. Macrocyclic agents such as gadoterate have lower retention potential than linear agents, although long-term data remain limited.
Sources for this answer
- Clariscan 0.5 mmol/ mL solution for injection — Current selected SmPCemc · Summary of Product Characteristics
- UK Government